D
Phathom Pharmaceuticals, Inc. PHAT
$4.41 $0.194.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 55.25M 26.27M 9.92M 2.59M 682.00K
Total Other Revenue -- -- -- -- --
Total Revenue 55.25M 26.27M 9.92M 2.59M 682.00K
Cost of Revenue 7.97M 4.33M 1.97M 593.00K 167.00K
Gross Profit 47.28M 21.95M 7.95M 2.00M 515.00K
SG&A Expenses 290.66M 270.98M 218.27M 161.34M 117.93M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 332.72M 314.20M 262.71M 209.78M 167.99M
Operating Income -277.47M -287.93M -252.79M -207.19M -167.31M
Income Before Tax -334.33M -339.45M -297.11M -246.63M -201.59M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -334.33 -339.45 -297.11 -246.63 -201.59
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -334.33M -339.45M -297.11M -246.63M -201.59M
EBIT -277.47M -287.93M -252.79M -207.19M -167.31M
EBITDA -276.67M -287.14M -252.07M -206.55M -166.74M
EPS Basic -5.35 -5.69 -5.13 -4.41 -3.89
Normalized Basic EPS -3.35 -3.56 -3.21 -2.76 -2.43
EPS Diluted -5.35 -5.69 -5.13 -4.41 -3.89
Normalized Diluted EPS -3.35 -3.56 -3.21 -2.76 -2.43
Average Basic Shares Outstanding 252.60M 238.85M 231.01M 220.95M 204.93M
Average Diluted Shares Outstanding 252.60M 238.85M 231.01M 220.95M 204.93M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings